title: Is long-term triple drug therapy required for maintaining kidney allograft tolerance? Effect of azathioprine withdrawal at three months posttransplantation.
authors.affiliation: Nephrology Department, Hôpital Henri Mondor, Créteil, France.
authors.forename: A
authors.initials: A
authors.lastname: Oncevski
authors.forename: G
authors.initials: G
authors.lastname: Rostoker
authors.forename: C
authors.initials: C
authors.lastname: Buisson
authors.forename: G
authors.initials: G
authors.lastname: Fruchaud
authors.forename: A
authors.initials: A
authors.lastname: Benmaadi
authors.forename: D
authors.initials: D
authors.lastname: Belghiti
authors.forename: D
authors.initials: D
authors.lastname: Chopin
authors.forename: C
authors.initials: C
authors.lastname: Abbou
authors.forename: P
authors.initials: P
authors.lastname: Bierling
authors.forename: P
authors.initials: P
authors.lastname: Romano
mesh_terms: D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000627:therapeutic use*; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use*; D002102:Cadaver; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000187:drug effects*; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000961:Antilymphocyte Serum; D001379:Azathioprine; D008775:Methylprednisolone